<p>*. The simulation model consists of 5 covariates, each with OR of 1.5. In analysis, we assume that only the last two covariates are considered.</p><p>$. In analysis, a more stringent threshold (10<sup>−4</sup>) is used for significance, compared to other simulation models (.05).</p><p>n: number of cases, assuming case:control ratio of 1∶1; RAF: risk allele frequency; OR<sub>g</sub>: odds ratio for risk allele; OR<sub>z</sub>: odds ratios for covariates; corr: correlation coefficient between causal variant and the last covariate; α<sub>max</sub>: variation in sample proportions (see “<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0114523#s2" target="_blank">Methods</a>”). Model 1–4 were simulated under the null hypo...
<p>NOTE: For Scenario 1, each informative covariate is correlated with <i>s</i> non-informative cova...
<p>(A) 20% associated SNPs for each phenotype and 75% extra overlaps between and and between and ...
<p>Note: <sup>a</sup> denote the proportions of YRI individuals in cases-controls, respectively.</p>...
<p>The simulation setting is described in <a href="http://www.plosone.org/article/info:doi/10.1371/j...
<p>Simulation parameters for Scenario I & II of the association between outcome <i>D</i>, exposure <...
<p>Characteristics of model simulation [<a href="http://www.plosone.org/article/info:doi/10.1371/jou...
<p>The first to third columns denote the effect sizes of SNP1, SNP2 and interaction in pure samples ...
<p>The simulation setting is similar to that described in <a href="http://www.plosone.org/article/in...
a<p>In each scenario (apart from 5c and 5d) the baseline regression coefficient was chosen to equal...
<p>The simulation setting is described in <a href="http://www.plosone.org/article/info:doi/10.1371/j...
<p>LME-RSI: a linear mixed-effects model with random slope and intercept; LME-RI: a linear mixed-eff...
<p>The total number of studies is denoted by <i>K</i> and <i>m</i> denotes the minor allele frequenc...
textabstractVarious modeling methods have been proposed to estimate the potential predictive ability...
<p>Results were based on 200 replicates. In each replicate, 500 cases and 500 controls were used to ...
<p>Means (±standard deviation) from Monte Carlo simulations (<i>n</i> = 10 over 100 years) for basel...
<p>NOTE: For Scenario 1, each informative covariate is correlated with <i>s</i> non-informative cova...
<p>(A) 20% associated SNPs for each phenotype and 75% extra overlaps between and and between and ...
<p>Note: <sup>a</sup> denote the proportions of YRI individuals in cases-controls, respectively.</p>...
<p>The simulation setting is described in <a href="http://www.plosone.org/article/info:doi/10.1371/j...
<p>Simulation parameters for Scenario I & II of the association between outcome <i>D</i>, exposure <...
<p>Characteristics of model simulation [<a href="http://www.plosone.org/article/info:doi/10.1371/jou...
<p>The first to third columns denote the effect sizes of SNP1, SNP2 and interaction in pure samples ...
<p>The simulation setting is similar to that described in <a href="http://www.plosone.org/article/in...
a<p>In each scenario (apart from 5c and 5d) the baseline regression coefficient was chosen to equal...
<p>The simulation setting is described in <a href="http://www.plosone.org/article/info:doi/10.1371/j...
<p>LME-RSI: a linear mixed-effects model with random slope and intercept; LME-RI: a linear mixed-eff...
<p>The total number of studies is denoted by <i>K</i> and <i>m</i> denotes the minor allele frequenc...
textabstractVarious modeling methods have been proposed to estimate the potential predictive ability...
<p>Results were based on 200 replicates. In each replicate, 500 cases and 500 controls were used to ...
<p>Means (±standard deviation) from Monte Carlo simulations (<i>n</i> = 10 over 100 years) for basel...
<p>NOTE: For Scenario 1, each informative covariate is correlated with <i>s</i> non-informative cova...
<p>(A) 20% associated SNPs for each phenotype and 75% extra overlaps between and and between and ...
<p>Note: <sup>a</sup> denote the proportions of YRI individuals in cases-controls, respectively.</p>...